Among these, extracellular matrix proteins (e.g., Fibrillin-1, FBN1; Periostin, POSTN), enzymes (i.e., Serine protease HTRA1), as well as the Metalloproteinase inhibitor 2 (TIMP2) were commonly up-regulated upon BC and CS treatments. The gene discussed is POSTN; the disease is breast cancer.